Your browser doesn't support javascript.
loading
Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
Salzman, C; Solomon, D; Miyawaki, E; Glassman, R; Rood, L; Flowers, E; Thayer, S.
Afiliación
  • Salzman C; Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Boston 02115.
J Clin Psychiatry ; 52(4): 177-80, 1991 Apr.
Article en En | MEDLINE | ID: mdl-1673123
ABSTRACT
In a double-blind, prospective study, 2 mg of intramuscular lorazepam and 5 mg of intramuscular haloperidol were equally effective in controlling aggression, agitation, and assaultive behavior. Although lorazepam and haloperidol produced an equivalent mean decrease in aggression, significantly more subjects who received lorazepam had a greater decrease in aggression ratings than haloperidol recipients; this effect was independent of sedation. Lorazepam produced significantly fewer extrapyramidal symptoms. These data support the current clinical practice of using lorazepam (alone, or in combination with a neuroleptic) for control of acute aggressive and assaultive behavior.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Agresión / Haloperidol / Lorazepam Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Clin Psychiatry Año: 1991 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Agresión / Haloperidol / Lorazepam Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Clin Psychiatry Año: 1991 Tipo del documento: Article